Overview

Modafinil for Treatment of Fatigue in ALS Patients

Status:
Completed
Trial end date:
2008-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this pilot study is to evaluate whether modafinil is helpful in alleviating fatigue, low energy, drowsiness and difficulty concentrating among patients with amyotrophic lateral sclerosis (ALS), and to evaluate incidence and frequency of adverse events, if any.
Phase:
Phase 4
Details
Lead Sponsor:
New York State Psychiatric Institute
Treatments:
Armodafinil
Modafinil